Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of vasopressin antagonism in heart failure: Outcome study with Tolvaptan (EVEREST)

Mihai Gheorghiade, Cesare Orlandi, John C. Burnett, David Demets, Liliana Grinfeld, Aldo Maggioni, Karl Swedberg, James E. Udelson, Faiez Zannad, Christopher Zimmer, Marvin A. Konstam*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

160 Scopus citations

Fingerprint

Dive into the research topics of 'Rationale and design of the multicenter, randomized, double-blind, placebo-controlled study to evaluate the efficacy of vasopressin antagonism in heart failure: Outcome study with Tolvaptan (EVEREST)'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science